SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 181.69-2.2%10:13 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (401)1/6/1997 10:59:00 PM
From: soozathelooza   of 32384
 
henry,

i heard about the recent buy recomendation
on XOMA. neuprex has been involved in 4 different
clinical trials, pre-clinical evaluation of i-prex
(treatment of eye infections) has been promising.
they control 13 issued patents related to BPI in
US and europe with 20 patents pending....
i'm stoked on this one for a med/long term play.
i've been accumulating between 4 1/4 and 5 1/2.

i thank you henry for all the useful information
you have provided on LGND. it seems like the
way targretin and panretin are moving thru the
pipeline along with H&Q coming, there couldn't
be a better time to own this gem.

thanks again henry,
paul.
(go pats)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News